Data / Form D filings / RLL, LLC
RLL, LLC: Form D filings
RLL, LLC, a biotechnology company in Lutherville, MD, filed 7 Form D notices with the SEC between 2018 and 2026. The latest, on April 6, 2026, reports $2 million sold of an offering with no set size to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11801 BERANS ROAD, Lutherville, MD, 21093
- Phone
- (410) 560-1737
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1755433
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | New notice | Indefinite | $1,984,621 | 11 | Apr 6, 2026 | sec.gov | |
| Jun 24, 2025 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Dec 2, 2024 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Jul 27, 2021 | New notice | Indefinite | $8,015,002 | 17 | Jul 26, 2021 | sec.gov | |
| Feb 26, 2020 | New notice | $2,632,136 | $1,537,316 | $1,094,820 | 2 | Feb 25, 2020 | sec.gov |
| Apr 5, 2019 | New notice | $1,000,000 | $500,000 | $500,000 | 1 | Mar 27, 2019 | sec.gov |
| Oct 9, 2018 | New notice | Indefinite | $684,211 | 1 | Sep 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| LAUREN SCHNAPER | Executive Officer, Director, Promoter | |
| LINDA MALKAS | Director | |
| ROBERT HICKEY | Director | |
| JONATHAN THOMAS | Executive Officer | |
| MICHAEL BRINKENHOFF | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RLL, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.